Our guidance and advice to help manage common infections and tackle antimicrobial resistance.
We've been asked by the Department of Health and Social Care to develop evidence-based, clinical syndrome specific guidance and advice to help slow the development of antimicrobial resistances.
Existing Public Health England guidance on management and treatment of common infections will be replaced over the next few years by new NICE/PHE antimicrobial prescribing guidelines.
Our guidelines offer evidence-based antimicrobial prescribing information for all care settings.
They focus on bacterial infections and appropriate antibiotic use. Each guideline topic features a visual summary of the recommendations, a guideline and an evidence review.
The visual summary is an overview of the guideline recommendations. It includes a prescribing table to support shared antimicrobial prescribing decisions in line with a health professional’s own clinical judgement.
An example of the draft visual summary for our sinusitis guideline
Published: February 2019
Published: December 2018
Published: December 2018
Summary of antimicrobial prescribing guidance - managing common infections
NICE and Public Health England (PHE) have brought together our information on managing common infections into a summary table. We will add a summary of new NICE guidance as it's published. We also indicate where new guidance is in development.
The evidence and rationales underpinning the information in the table can be accessed by clicking on the hyperlinks or the visual summary icons in the document.
The processes used by each organisation to develop their guidance differ. The process for developing the NICE guidelines can be found in the interim process guide. The process for developing the PHE guidance is briefly outlined on the PHE website in the PHE context, references and rationales document with further information available upon request.
This is the first time both sets of national guidance have been brought together and we would welcome your feedback. Please email email@example.com if you have any feedback to help improve future versions.
Fluoroquinolone antibiotics: In March 2019, the Medicines and Healthcare products Regulatory Agency issued restrictions and precautions for the use of fluoroquinolone antibiotics because of rare reports of disabling and potentially long-lasting or irreversible side effects (see Drug Safety Update for details). NICE is reviewing recommendations relating to fluoroquinolone antibiotics.
Our antimicrobial evidence summaries provide commissioners, providers and health professionals with a summary of the best available evidence for antimicrobials.
We are currently developing guideline recommendations on the following topics:
Why is our guidance and advice needed?
The World Health Organization states that 'antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective'.
Resistance to antimicrobials is complex and increasing. Combined with a lack of new antimicrobial medicines, there is a growing risk that infections may not be treatable in the future.
The Department of Health and Social Care asked us to develop guidelines to help slow antimicrobial resistance. These guidelines are evidence-based and clinical syndrome specific.
Read more about the importance of antimicrobial resistance at Health matters: antimicrobial resistance.
When we as health professionals are discussing treatments for common infections with patients, it is important to talk about the benefits and harms of prescribing antibiotics. This includes the risks of antimicrobial resistance and the threat this poses to public health.Tessa Lewis, GP and Chair of the managing common infections advisory committee
How we develop guidance and advice
Antimicrobial prescribing guidelines
Find out how we develop antimicrobial prescribing guidance in the:
The scope sets out the remit for the programme:
Find out how we develop our advice in the:
Current NICE guidance and standards on antimicrobial stewardship: